Kshama M. Daphtary, MD, MBI: Acceleron: Major Stockholder (not including mutual funds) (Ongoing); Gilead: Major Stockholder (not including mutual funds) (Ongoing); Merck: Major Stockholder (not including mutual funds) (Ongoing); Organon: Major Stockholder (not including mutual funds) (Ongoing); Roche: Major Stockholder (not including mutual funds) (Ongoing)
Review the biology of lymphatic dysfunction and implementation of novel imaging diagnostic techniques.
